Interactions between polycyclic aromatic hydrocarbons in complex mixtures and implications for cancer risk assessment

Toxicology

Volumn 321, Issue 1, 2014, Pages 27-39

  Jarvis, Ian W H ^a   Dreij, Kristian ^a   Mattsson, Åse ^a   Jernström, Bengt ^a   Stenius, Ulla ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Benzo a pyrene; Cancer; Complex mixtures; Polycyclic aromatic hydrocarbons; Risk assessment

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CARCINOGEN; POLYCYCLIC AROMATIC HYDROCARBON; REACTIVE OXYGEN METABOLITE;

CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; CHEMICAL COMPOSITION; DNA ADDUCT; DNA BINDING; DNA DAMAGE; DNA METHYLATION; DNA SEQUENCE; DRUG EXPOSURE; DRUG MIXTURE; EXHAUST GAS; FOOD; HEALTH HAZARD; HUMAN; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; POLLUTANT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SMOKING;

BENZO[A]PYRENE; CANCER; COMPLEX MIXTURES; POLYCYCLIC AROMATIC HYDROCARBONS; RISK ASSESSMENT;

ANIMALS; BIOTRANSFORMATION; CARCINOGENS; COMPLEX MIXTURES; DNA; HUMANS; NEOPLASMS; POLYCYCLIC HYDROCARBONS, AROMATIC; RISK ASSESSMENT;

EID: 84899022334     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2014.03.012     Document Type: Review

References (171)

1. Albert R.E., et al. Comparative potency method for cancer risk assessment: application to diesel particulate emissions. Risk Anal. 1983, 3(2):101-117.
2. Alexandrov K., et al. The critical DNA damage by benzo(a)pyrene in lung tissues of smokers and approaches to preventing its formation. Toxicol. Lett. 2010, 198(1):63-68.
3. Andrysik Z., et al. Activation of the aryl hydrocarbon receptor is the major toxic mode of action of an organic extract of a reference urban dust particulate matter mixture: the role of polycyclic aromatic hydrocarbons. Mutat. Res. 2011, 714(1-2):53-62.
4. ATSDR Toxicological Profile for Polycyclic Aromatic Hydrocarbons (PAHs) 1995, U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
5. ATSDR Guidance Manual for the Assessment of Joint Toxic Actions of Chemical Mixtures 2004, U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
6. Backhaus T., et al. Hazard and Risk Assessment of Chemical Mixtures under REACH - State of the Art, Gaps and Options for Improvement. Report PM/3 2010 2010, The Swedish National Chemicals Inspectorate, Stockholm, Sweden.
7. Baird W.M., et al. Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ. Mol. Mutagen. 2005, 45(2-3):106-114.
8. Bauer M., et al. Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(52):21105-21110.
9. Bauer M., et al. Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant. PLoS ONE 2012, 7(6):e39956.
10. Bihari N., Fafandel M. Interspecies differences in DNA single strand breaks caused by benzo(a)pyrene and marine environment. Mutat. Res. 2004, 552(1-2):209-217.
11. Binkova B., Sram R.J. The genotoxic effect of carcinogenic PAHs, their artificial and environmental mixtures (EOM) on human diploid lung fibroblasts. Mutat. Res. 2004, 547(1-2):109-121.
12. Boffetta P., et al. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 1997, 8(3):444-472.
13. Bollati V., et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007, 67(3):876-880.
14. Bos J.L. ras oncogenes in human cancer: a review. Cancer Res. 1989, 49(17):4682-4689.
15. Bosetti C., et al. Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. Ann. Oncol. 2007, 18(3):431-446.
16. Boström C.E., et al. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ. Health Perspect. 2002, 110(Suppl. 3):451-488.
17. Bouchard M., et al. Urinary excretion kinetics of 1-hydroxypyrene following intravenous administration of binary and ternary mixtures of polycyclic aromatic hydrocarbons in rat. Arch. Toxicol. 1998, 72(8):475-482.
18. Broyde S., et al. Elucidating structure-function relationships in bulky DNA lesions: from solution structures to polymerases. The Chemical Biology of DNA Damage 2010, 331-352. Wiley-VCH Verlag GmbH & Co. KGaA. N. Geacintov, S. Broyde (Eds.).
19. Buterin T., et al. Unrepaired fjord region polycyclic aromatic hydrocarbon-DNA adducts in ras codon 61 mutational hot spots. Cancer Res. 2000, 60(7):1849-1856.
20. Cherng S.H., et al. Suppressive effect of 1-nitropyrene on benzo[a]pyrene-induced CYP1A1 protein expression in HepG2 cells. Toxicol. Lett. 2006, 161(3):236-243.
21. Cherng S.H., et al. Benzo[g,h,i]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1 gene expression by aryl hydrocarbon receptor pathway. Toxicol. Appl. Pharmacol. 2001, 170(1):63-68.
22. Chou M.W., Fu P.P. Evidence for the metabolic formation of a vicinal dihydrodiol-epoxide from the potent mutagen 1-nitrobenzo(A)pyrene. Biochem. Biophys. Res. Commun. 1983, 117(2):541-548.
23. Chuang J.C., et al. Chemical characterization of mutagenic fractions of particles from indoor coal combustion: a study of lung cancer in Xuan Wei, China. Environ. Sci. Technol. 1992, 26(5):999-1004.
24. Ciccia A., Elledge S.J. The DNA damage response: making it safe to play with knives. Mol. Cell 2010, 40(2):179-204.
25. Claxton L.D., et al. The genotoxicity of ambient outdoor air, a review: salmonella mutagenicity. Mutat. Res. 2004, 567(2-3):347-399.
26. Collins J.F., et al. Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul. Toxicol. Pharmacol. 1998, 28(1):45-54.
27. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 1982, 42(12):4875-4917.
28. Courter L.A., et al. The influence of diesel exhaust on polycyclic aromatic hydrocarbon-induced DNA damage, gene expression, and tumor initiation in Sencar mice in vivo. Cancer Lett. 2008, 265(1):135-147.
29. Courter L.A., et al. Urban dust particulate matter alters PAH-induced carcinogenesis by inhibition of CYP1A1 and CYP1B1. Toxicol. Sci. 2007, 95(1):63-73.
30. Courter L.A., et al. Diesel exhaust influences carcinogenic PAH-induced genotoxicity and gene expression in human breast epithelial cells in culture. Mutat. Res. 2007, 625(1-2):72-82.
31. Culp S.J., et al. A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. Carcinogenesis 1998, 19(1):117-124.
32. Dai Y., Grant S. New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin. Cancer Res. 2010, 16(2):376-383.
33. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 2004, 567(2-3):447-474.
34. DeMarini D.M., et al. Lung tumor KRAS and TP53 mutations in nonsmokers reflect exposure to PAH-rich coal combustion emissions. Cancer Res. 2001, 61(18):6679-6681.
35. Deutsch-Wenzel R.P., et al. Investigation on the carcinogenicity of emission condensate from brown coal-fired residential furnaces applied to mouse skin. Cancer Lett. 1984, 25(1):103-111.
36. DiGiovanni J., et al. Anticarcinogenic and cocarcinogenic effects of benzo[e]pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons. Carcinogenesis 1982, 3(4):371-375.
37. Dipple A., et al. Optically active benzo[c]phenanthrene diol epoxides bind extensively to adenine in DNA. Nature 1987, 327(6122):535-536.
38. Djuric Z., et al. Oxidative microsomal metabolism of 1-nitropyrene and DNA-binding of oxidized metabolites following nitroreduction. Carcinogenesis 1986, 7(7):1073-1079.
39. Dreij K., et al. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells. Chem. Res. Toxicol. 2005, 18(4):655-664.
40. EC State of the Art Report on Mixture Toxicity 2009.
41. ECETOC Derivation of assessment factors for human health risk assessment (TR 86) 2003, European Centre for Ecotoxicology and Toxicology of Chemicals, Brussels.
42. ECETOC Guidance on assessment factors to derive a DNEL (TR 110) 2010, European Centre for Ecotoxicology and Toxicology of Chemicals, Brussels.
43. EFSA Scientific opinion of the panel on contaminants in the food chain on a request from the European commission on polycyclic aromatic hydrocarbons in food. EFSA J. 2008, 724:1-114.
44. Eoff R.L., et al. Impact of chemical adducts on tranlesion synthesis in replicative and bypass DNA polymerases: from structure to function. The Chemical Biology of DNA Damage 2010, 299-330. Wiley-VCH Verlag GmbH & Co. KGaA. N. Geacintov, S. Broyde (Eds.).
45. EPA No Significant Risk Levels (NSRLs) for the Proposition 65 carcinogens benzo[b]fluoranthene, benzo[j]fluoranthene, chrysene, dibenzo[a,h]pyrene, dibenzo[a,i]pyrene, and 5-methylchrysene by the oral route 2004, Office of Environmental Health Hazard Assessment, Reproductive and Cancer Hazard Assessment Section, Oakland, CA.
46. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 2008, 358(11):1148-1159.
47. Falahatpisheh M., et al. Inducible cytochrome P450 activities in renal glomerular mesangial cells: biochemical basis for antagonistic interactions among nephrocarcinogenic polycyclic aromatic hydrocarbons. J. Carcinogen. 2004, 3(1):12.
48. Fernandez-Capetillo O., et al. H2AX: the histone guardian of the genome. DNA Repair (Amst.) 2004, 3(8-9):959-967.
49. Flowers L., et al. Health assessment of polycyclic aromatic hydrocarbon mixtures: current practices and future directions. Polycycl. Aromat. Compd. 2002, 22(3-4):811-821.
50. Gabelova A., et al. Sustained induction of cytochrome P4501A1 in human hepatoma cells by co-exposure to benzo[a]pyrene and 7H-dibenzo[c,g]carbazole underlies the synergistic effects on DNA adduct formation. Toxicol. Appl. Pharmacol. 2013, 271(1):1-12.
51. Gaylor D.W., et al. Cancer risk estimation for mixtures of coal tars and benzo(a)pyrene. Risk Anal. 2000, 20(1):81-85.
52. Goldstein L.S., et al. Tumors and DNA adducts in mice exposed to benzo[a]pyrene and coal tars: implications for risk assessment. Environ. Health Perspect. 1998, 106(Suppl. 6):1325-1330.
53. Gray D.L., et al. The effects of a binary mixture of benzo(a)pyrene and 7H-dibenzo(c,g)carbazole on lung tumors and K-ras oncogene mutations in strain A/J mice. Exp. Lung Res. 2001, 27(3):245-253.
54. Grimmer G., et al. Contribution of polycyclic aromatic compounds to the carcinogenicity of sidestream smoke of cigarettes evaluated by implantation into the lungs of rats. Cancer Lett. 1988, 43(3):173-177.
55. Grimmer G., et al. Contribution of polycyclic aromatic hydrocarbons and nitro-derivatives to the carcinogenic impact of diesel engine exhaust condensate evaluated by implantation into the lungs of rats. Cancer Lett. 1987, 37(2):173-180.
56. Grimmer G., et al. Contribution of polycyclic aromatic hydrocarbons and polar polycyclic aromatic compounds to the carcinogenic impact of flue gas condensate from coal-fired residential furnaces evaluated by implantation into the rat lung. J. Natl. Cancer Inst. 1987, 78(5):935-942.
57. Grimmer G., et al. The contribution of polycyclic aromatic hydrocarbons to the carcinogenic impact of emission condensate from coal-fired residential furnaces evaluated by topical application to the skin of mice. Cancer Lett. 1984, 23(2):167-176.
58. Grimmer G., et al. The contribution of polycyclic aromatic hydrocarbon fractions with different boiling ranges to the carcinogenic impact of emission condensate from coal fired residential furnaces as evaluated by topical application to the skin of mice. Cancer Lett. 1985, 28(2):203-211.
59. Grimmer G., et al. On the contribution of polycyclic aromatic hydrocarbons to the carcinogenic impact of automobile exhaust condensate evaluated by local application onto mouse skin. Cancer Lett. 1983, 21(1):105-113.
60. Grimmer G., et al. Quantification of the carcinogenic effect of polycyclic aromatic hydrocarbons in used engine oil by topical application onto the skin of mice. Int. Arch. Occup. Environ. Health 1982, 50(1):95-100.
61. Hainaut P., et al. IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res. 1998, 26(1):205-213.
62. Harris K.L., et al. Benzo(a)pyrene modulates fluoranthene-induced cellular responses in HT-29 colon cells in a dual exposure system. Environ. Toxicol. Pharmacol. 2013, 36(2):358-367.
63. Hollstein M., et al. p53 mutations in human cancers. Science 1991, 253(5015):49-53.
64. Howsam M., Jones K.C. Sources of PAHs in the environment. PAHs and Related Compounds: The Handbook of Environmental Chemistry 1998, vol. 3/3I:137-174. Springer.
65. Huang X., et al. Effects of base sequence context on translesion synthesis past a bulky (+)-trans-anti-B[a]P-N2-dG lesion catalyzed by the Y-family polymerase pol kappa. Biochemistry 2003, 42(8):2456-2466.
66. Huang Y.C. The role of in vitro gene expression profiling in particulate matter health research. J. Toxicol. Environ. Health B: Crit. Rev. 2013, 16(6):381-394.
67. Huberman E., et al. Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 1976, 73(2):607-611.
68. Hughes N.C., Phillips D.H. Covalent binding of dibenzpyrenes and benzo[a]pyrene to DNA: evidence for synergistic and inhibitory interactions when applied in combination to mouse skin. Carcinogenesis 1990, 11(9):1611-1619.
69. Hussain S.P., et al. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res. 2001, 61(17):6350-6355.
70. IARC Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2004, vol. 83. IARC Press, Lyon, France.
71. IARC Some Non-Heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2010, vol. 92. IARC Press.
72. IPCS Selected Non-heterocyclic Polycyclic Aromatic Hydrocarbons. Environmental Health Criteria 202 1998, International Programme on Chemical Safety, World Health Organization, Geneva.
73. IPCS Assessment of combined exposures to multiple chemicals: Report of a WHO/IPCS international workshop 2009.
74. Jarvis I.W., et al. Persistent activation of DNA damage signaling in response to complex mixtures of PAHs in air particulate matter. Toxicol. Appl. Pharmacol. 2013, 266(3):408-418.
75. Jerina D.M., et al. Reactivity and tumorigenicity of bay-region diol epoxides derived from polycyclic aromatic hydrocarbons. Adv. Exp. Med. Biol. 1986, 197:11-30.
76. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128(4):683-692.
77. KEMI Proposals for the use of assessment (uncertainty) factors - application to risk assessment for plant protection products, industrial chemicals and biocidal products within the European union No 1/03 2003, The Swedish National Chemicals Inspectorate, Stockholm, Sweden.
78. Knasmuller S., et al. Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat. Res. 1998, 402(1-2):185-202.
79. Kroese E.D., et al. Tumorigenic Effects in Wistar Rats Orally Administered Benzo[a]pyrene for Two Years (Gavage Studies). Implications for Human Cancer Risks Associated with Oral Exposure to Polycyclic Aromatic Hydrocarbons 2001, National Institute of Public Health and the Environment, Bilthoven, Netherlands.
80. Kropachev K., et al. Adenine-DNA adducts derived from the highly tumorigenic Dibenzo[a,l]pyrene are resistant to nucleotide excision repair while guanine adducts are not. Chem. Res. Toxicol. 2013, 26(5):783-793.
81. Kuljukka-Rabb T., et al. Time- and dose-dependent DNA binding of PAHs derived from diesel particle extracts, benzo[a]pyrene and 5-methychrysene in a human mammary carcinoma cell line (MCF-7). Mutagenesis 2001, 16(4):353-358.
82. Larsen J.C., Larsen P.B. "Chemical Carcinogens" in air pollution and health. Issues in Environmental Science and Technology 1998, The Royal Society of Chemistry. R.E. Hester, R.M. Harrison (Eds.).
83. Lewtas J. Development of a comparative potency method for cancer risk assessment of complex mixtures using short-term in vivo and in vitro bioassays. Toxicol. Ind. Health 1985, 1(4):193-203.
84. Lodovici M., Bigagli E. Oxidative stress and air pollution exposure. J. Toxicol. 2011, 2011:487074.
85. Lovejoy C.A., Cortez D. Common mechanisms of PIKK regulation. DNA Repair (Amst.) 2009, 8(9):1004-1008.
86. Ma C.X., et al. Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol. Med. 2011, 17(2):88-96.
87. Mah L.J., et al. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010, 24(4):679-686.
88. Mahadevan B., et al. Altered gene expression patterns in MCF-7 cells induced by the urban dust particulate complex mixture standard reference material 1649a. Cancer Res. 2005, 65(4):1251-1258.
89. Mahadevan B., et al. Effect of a standardized complex mixture derived from coal tar on the metabolic activation of carcinogenic polycyclic aromatic hydrocarbons in human cells in culture. Chem. Res. Toxicol. 2005, 18(2):224-231.
90. Mahadevan B., et al. Competitive inhibition of carcinogen-activating CYP1A1 and CYP1B1 enzymes by a standardized complex mixture of PAH extracted from coal tar. Int. J. Cancer 2007, 120(6):1161-1168.
91. Malcolm H.M., Dobson S. The calculation of an environmental assessment level (EAL) for atmospheric PAHs using relative potencies. Report No. DoE/HMIP/RR/94/041 1994, Department of the Environment, London, England.
92. Marston C.P., et al. Effect of a complex environmental mixture from coal tar containing polycyclic aromatic hydrocarbons (PAH) on the tumor initiation, PAH-DNA binding and metabolic activation of carcinogenic PAH in mouse epidermis. Carcinogenesis 2001, 22(7):1077-1086.
93. Martin O.V., et al. Dispelling urban myths about default uncertainty factors in chemical risk assessment - sufficient protection against mixture effects?. Environ. Health 2013, 12(1):53.
94. Mason J.M., et al. Ability of short-term tests to predict carcinogenesis in rodents. Annu. Rev. Pharmacol. Toxicol. 1990, 30:149-168.
95. Mattsson A., et al. Exposure of HepG2 cells to low levels of PAH-containing extracts from contaminated soils results in unpredictable genotoxic stress responses. Environ. Mol. Mutagen. 2009, 50(4):337-348.
96. Mauderly J.L. Toxicological approaches to complex mixtures. Environ. Health Perspect. 1993, 101(Suppl. 4):155-165.
97. May W.E., et al. Standard reference materials for chemical and biological studies of complex environmental samples. Mutat. Res. 1992, 276(1-2):11-22.
98. McCoull K.D., et al. Synthesis and characterization of polycyclic aromatic hydrocarbon o-quinone depurinating N7-guanine adducts. Chem. Res. Toxicol. 1999, 12(3):237-246.
99. Mordukhovich I., et al. Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors. Environ. Health Perspect. 2010, 118(4):511-518.
100. Muller P. Scientific Criteria Document for Multimedia Standards Development, Polycyclic Aromatic Hydrocarbons (PAH). Part 1, Hazard Identification and Dose-response Assessment: Report 1997, Standards Development Branch, Ontario Ministry of Environment and Energy.
101. Musafia-Jeknic T., et al. Long-term effects of a standardized complex mixture of urban dust particulate on the metabolic activation of carcinogenic polycyclic aromatic hydrocarbons in human cells in culture. Toxicol. Sci. 2005, 88(2):358-366.
102. Nebert D.W., et al. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 2004, 279(23):23847-23850.
103. Nesnow S., et al. Lung tumorigenic interactions in strain A/J mice of five environmental polycyclic aromatic hydrocarbons. Environ. Health Perspect. 1998, 106(Suppl. 6):1337-1346.
104. Nesnow S., et al. Mouse skin tumor initiation-promotion and complete carcinogenesis bioassays: mechanisms and biological activities of emission samples. Environ. Health Perspect. 1983, 47:255-268.
105. Nisbet I.C., LaGoy P.K. Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs). Regul. Toxicol. Pharmacol. 1992, 16(3):290-300.
106. Niziolek-Kierecka M., et al. gammaH2AX, pChk1, and Wip1 as potential markers of persistent DNA damage derived from dibenzo[a,l]pyrene and PAH-containing extracts from contaminated soils. Chem. Res. Toxicol. 2012, 25(4):862-872.
107. NRC National Research Council. Toxicity Testing in the 21st Century: A Vision and a Strategy 2007, The National Academies Press, Washington, DC.
108. NTP NTP research concept: Polycyclic Aromatic Hydrocarbons (PAHs) - draft. NTP Board of Scientific Counselors Meeting 2012.
109. Oh S.M., et al. Organic extracts of urban air pollution particulate matter (PM2.5)-induced genotoxicity and oxidative stress in human lung bronchial epithelial cells (BEAS-2B cells). Mutat. Res. 2011, 723(2):142-151.
110. Ohe T., et al. Mutagens in surface waters: a review. Mutat. Res. 2004, 567(2-3):109-149.
111. Park J.H., et al. Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGuo) by PAH o-quinones: involvement of reactive oxygen species and copper(II)/copper(I) redox cycling. Chem. Res. Toxicol. 2005, 18(6):1026-1037.
112. Park J.H., et al. Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(19):6846-6851.
113. Park J.H., et al. Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by the aldo-keto-reductases (AKRs) generate abasic sites, oxidized pyrimidines, and 8-oxo-dGuo via reactive oxygen species. Chem. Res. Toxicol. 2006, 19(5):719-728.
114. Patil M., et al. Checkpoint kinase 1 in DNA damage response and cell cycle regulation. Cell. Mol. Life Sci. 2013, 70(21):4009-4021.
115. Pavanello S., et al. Global and gene-specific promoter methylation changes are related to anti-B[a]PDE-DNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals. Int. J. Cancer 2009, 125(7):1692-1697.
116. Pavanello S., et al. Shorter telomere length in peripheral blood lymphocytes of workers exposed to polycyclic aromatic hydrocarbons. Carcinogenesis 2010, 31(2):216-221.
117. Pelkonen O., Nebert D.W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 1982, 34(2):189-222.
118. Penning T.M., et al. Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. Chem. Res. Toxicol. 1999, 12(1):1-18.
119. Pereira M.A. Skin tumorigenesis research data base. J. Am. Coll. Toxicol. 1982, 1:47-82.
120. Peters A., et al. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001, 103(23):2810-2815.
121. Phillips D.H. Polycyclic aromatic hydrocarbons in the diet. Mutat. Res. 1999, 443(1-2):139-147.
122. Pohjola S.K., et al. DNA binding of polycyclic aromatic hydrocarbons in a human bronchial epithelial cell line treated with diesel and gasoline particulate extracts and benzo[a]pyrene. Mutagenesis 2003, 18(5):429-438.
123. Pope C.A., et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. J. Am. Med. Assoc. 2002, 287(9):1132-1141.
124. Prior I.A., et al. A comprehensive survey of Ras mutations in cancer. Cancer Res. 2012, 72(10):2457-2467.
125. Pufulete M., et al. Approaches to carcinogenic risk assessment for polycyclic aromatic hydrocarbons: a UK perspective. Regul. Toxicol. Pharmacol. 2004, 40(1):54-66.
126. Ralston S.L., et al. Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti (11R,12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. Carcinogenesis 1995, 16(12):2899-2907.
127. Ravindra K., et al. Atmospheric polycyclic aromatic hydrocarbons: source attribution, emission factors and regulation. Atmos. Environ. 2008, 42(13):2895-2921.
128. Rice J.E., et al. The influence of fluoranthene on the metabolism and DNA binding of benzo[a]pyrene in vivo in mouse skin. Chem. Biol. Interact. 1988, 68(1-2):127-136.
129. Rice J.E., et al. Fluoranthene and pyrene enhance benzo[a]pyrene - DNA adduct formation in vivo in mouse skin. Cancer Lett. 1984, 24(3):327-333.
130. Robinson M., et al. Carcinogenic effects in A/J mice of particulate of a coal tar paint used in potable water systems. Cancer Lett. 1987, 34(1):49-54.
131. Rogakou E.P., et al. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273(10):5858-5868.
132. Rogan E.G., et al. Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 1993, 6(3):356-363.
133. Ross J.A., Nesnow S. Polycyclic aromatic hydrocarbons: correlations between DNA adducts and ras oncogene mutations. Mutat. Res. 1999, 424(1-2):155-166.
134. Rossner P., et al. Nucleotide excision repair is not induced in human embryonic lung fibroblasts treated with environmental pollutants. PLoS ONE 2013, 8(7):e69197.
135. Sancar A., et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73:39-85.
136. SCHER, et al. Opinion on the Toxicity and Assessment of Chemical Mixtures 2012.
137. Schmidt C.W. TOX 21, new dimensions of toxicity testing. Environ. Health Perspect. 2009, 117(8):A348-A353.
138. Schneider K., et al. Cancer risk assessment for oral exposure to PAH mixtures. J. Appl. Toxicol. 2002, 22(1):73-83.
139. Sen B., et al. Transcriptional responses to complex mixtures: a review. Mutat. Res. 2007, 636(1-3):144-177.
140. Sevastyanova O., et al. In vitro genotoxicity of PAH mixtures and organic extract from urban air particles part II: human cell lines. Mutat. Res. 2007, 620(1-2):123-134.
141. Shimada T., Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 2004, 95(1):1-6.
142. Shimada T., et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 1996, 56(13):2979-2984.
143. Shou M., et al. Reactivity of benzo[a]pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis 1993, 14(3):475-482.
144. Siddens L.K., et al. Polycyclic aromatic hydrocarbons as skin carcinogens: comparison of benzo[a]pyrene, dibenzo[def,p]chrysene and three environmental mixtures in the FVB/N mouse. Toxicol. Appl. Pharmacol. 2012, 264(3):377-386.
145. Silkworth J.B., et al. Comparison of TCDD and PCB CYP1A induction sensitivities in fresh hepatocytes from human donors, sprague-dawley rats, and rhesus monkeys and HepG2 cells. Toxicol. Sci. 2005, 87(2):508-519.
146. Sims P., Grover P.L. Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv. Cancer Res. 1974, 20:165-274.
147. Sims P., et al. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature 1974, 252(5481):326-328.
148. Slaga T.J., et al. The effects of weak or non-carcinogenic polycyclic hydrocarbons on 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene skin tumor-initiation. Cancer Lett. 1979, 7(1):51-59.
149. Smolarek T.A., Baird W.M. Benzo[e]pyrene-induced alterations in the binding of benzo[a]pyrene to DNA in hamster embryo cell cultures. Carcinogenesis 1984, 5(8):1065-1069.
150. Smolarek T.A., et al. Benzo(e)pyrene-induced alterations in the binding of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene to DNA in Sencar mouse epidermis. Cancer Res. 1987, 47(14):3701-3706.
151. Staal Y.C.M., et al. Binary PAH mixtures cause additive or antagonistic effects on gene expression but synergistic effects on DNA adduct formation. Carcinogenesis 2007, 28(12):2632-2640.
152. Staal Y.C.M., et al. Interactions between polycyclic aromatic hydrocarbons in binary mixtures: effects on gene expression and DNA adduct formation in precision-cut rat liver slices. Mutagenesis 2008, 23(6):491-499.
153. Suh M., et al. Formation and persistence of benzo[a]pyrene-DNA adducts in mouse epidermis in vivo: importance of adduct conformation. Carcinogenesis 1995, 16(10):2561-2569.
154. Szeliga J., Dipple A. DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem. Res. Toxicol. 1998, 11(1):1-11.
155. Tarantini A., et al. Relative contribution of DNA strand breaks and DNA adducts to the genotoxicity of benzo[a]pyrene as a pure compound and in complex mixtures. Mutat. Res. 2009, 671(1-2):67-75.
156. Tarantini A., et al. Polycyclic aromatic hydrocarbons in binary mixtures modulate the efficiency of benzo[a]pyrene to form DNA adducts in human cells. Toxicology 2011, 279:36-44.
157. Tobiszewski M., Namieśnik J. PAH diagnostic ratios for the identification of pollution emission sources. Environ. Pollut. 2012, 162:110-119.
158. Tung E.W., et al. Benzo[a]pyrene increases DNA double strand break repair in vitro and in vivo: a possible mechanism for benzo[a]pyrene-induced toxicity. Mutat. Res. 2014, 760:64-69.
159. USEPA Supplementary Guidance for Conducting Health Risk Assessment of Chemical Mixtures (EPA/630/R-00/002) 2000, U.S. Environmental Protection Agency, Washington, DC.
160. USEPA Concepts, Methods and Data Sources for Cumulative Health Risk Assessment of Multiple Chemicals, Exposures and Effects: A Resource Document (EPA/600/R-06/013F) 2007, U.S. Environmental Protection Agency, Washington, DC.
161. USEPA Development of a Relative Potency Factor (RPF) Approach for Polycyclic Aromatic Hydrocarbon (PAH) Mixtures (External Review Draft, EPA/635/R-08/012A) 2010, U.S. Environmental Protection Agency, Washington, DC.
162. Van Tiem L.A., Di Giulio R.T. AHR2 knockdown prevents PAH-mediated cardiac toxicity and XRE- and ARE-associated gene induction in zebrafish (Danio rerio). Toxicol. Appl. Pharmacol. 2011, 254(3):280-287.
163. Weyand E.H., et al. Differences in the tumorigenic activity of a pure hydrocarbon and a complex mixture following ingestion: benzo[a]pyrene vs manufactured gas plant residue. Chem. Res. Toxicol. 1995, 8(7):949-954.
164. White P.A. The genotoxicity of priority polycyclic aromatic hydrocarbons in complex mixtures. Mutat. Res. 2002, 515(1-2):85-98.
165. White P.A., Claxton L.D. Mutagens in contaminated soil: a review. Mutat. Res. 2004, 567(2-3):227-345.
166. WHO Air Quality Guidelines for Europe 2000, World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark. 2nd ed.
167. Willett K.L., et al. In vivo and in vitro inhibition of CYP1A-dependent activity in Fundulus heteroclitus by the polynuclear aromatic hydrocarbon fluoranthene. Toxicol. Appl. Pharmacol. 2001, 177(3):264-271.
168. Yauk C., et al. Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(2):605-610.
169. Zeng Y. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature 1998, 395(6701):507-510.
170. Zhang L., et al. The role of human aldo-keto reductases in the metabolic activation and detoxication of polycyclic aromatic hydrocarbons: interconversion of PAH catechols and PAH o-quinones. Front. Pharmacol. 2012, 3:193.
171. Zhao H., Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 2001, 21(13):4129-4139.